$53.3 Million is the total value of Healthcare Value Capital, LLC's 19 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 400.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | GILEAD SCIENCES INCcall | $10,134,000 | – | 150,000 | +100.0% | 19.01% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $5,860,000 | – | 20,000 | +100.0% | 10.99% | – |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $4,802,000 | +14.9% | 120,000 | +20.0% | 9.01% | -44.1% |
| GILD | Buy | GILEAD SCIENCES INC | $4,729,000 | +45.5% | 70,000 | +40.0% | 8.87% | -29.2% |
| ABBV | New | ABBVIE INCcall | $3,636,000 | – | 50,000 | +100.0% | 6.82% | – |
| JNJ | New | JOHNSON & JOHNSONcall | $3,482,000 | – | 25,000 | +100.0% | 6.53% | – |
| CVS | New | CVS HEALTH CORPcall | $2,725,000 | – | 50,000 | +100.0% | 5.11% | – |
| GNLN | New | GREENLANE HLDGS INCcl a | $2,398,000 | – | 250,000 | +100.0% | 4.50% | – |
| PFE | New | PFIZER INC | $2,166,000 | – | 50,000 | +100.0% | 4.06% | – |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $1,240,000 | +74.4% | 200,000 | +100.0% | 2.33% | -15.1% |
| GWPH | New | GW PHARMACEUTICALS PLCput | $1,034,000 | – | 6,000 | +100.0% | 1.94% | – |
| CRON | New | CRONOS GROUP INCput | $799,000 | – | 50,000 | +100.0% | 1.50% | – |
| ATRS | New | ANTARES PHARMA INCcall | $658,000 | – | 200,000 | +100.0% | 1.23% | – |
| VIXY | New | PROSHARES TR IIcall | $535,000 | – | 25,000 | +100.0% | 1.00% | – |
| TYME | New | TYME TECHNOLOGIES INCcall | $122,000 | – | 100,000 | +100.0% | 0.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.